Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/18/1997 | WO1997047358A1 Synthetic hepatitis c genes |
12/18/1997 | WO1997047327A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
12/18/1997 | WO1997047326A1 INHIBITION OF Ii SYNTHESIS |
12/18/1997 | WO1997047325A1 New composition and methods |
12/18/1997 | WO1997047321A1 Use of chimeric vaccinia virus complement control proteins to inhibit complement |
12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047314A1 Use of substrate subtraction libraries to distinguish enzyme specificities |
12/18/1997 | WO1997047306A1 δ-ERYTHROID KRÜPPEL-LIKE FACTORS AND METHODS OF USE |
12/18/1997 | WO1997047197A1 Compositions and methods for administering borrelia dna |
12/18/1997 | WO1997047183A1 Genes enhancing disease resistance in plants |
12/18/1997 | WO1997047172A1 Vitamin d receptor isoform protein |
12/18/1997 | WO1997043419A3 The spindly gene, methods of identification and use |
12/18/1997 | WO1997041823A3 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE) |
12/18/1997 | WO1997040148A3 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors |
12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
12/18/1997 | WO1997035194A3 Enantiomeric screening process, and compositions therefor |
12/18/1997 | WO1997035023A3 Alteration of amino acid compositions in seeds |
12/18/1997 | WO1997035015A3 Tyrosine-phosphatase-related protein |
12/18/1997 | WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells |
12/18/1997 | WO1997024451A3 Episomal vector and uses thereof |
12/18/1997 | DE19635347C1 Oligo:nucleotide probes specific for fungal species |
12/18/1997 | CA2258858A1 Novel anti-hiv ribozymes |
12/18/1997 | CA2258745A1 Nuclease protection assays |
12/18/1997 | CA2258742A1 Padlock probe detection |
12/18/1997 | CA2258553A1 Cellular injury response element and uses thereof |
12/18/1997 | CA2258511A1 Method for polynucleotide sequencing |
12/18/1997 | CA2258127A1 Genes enhancing disease resistance in plants |
12/18/1997 | CA2258016A1 Compositions and methods for administering borrelia dna |
12/18/1997 | CA2258007A1 Methods and compositions for transforming cells |
12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | CA2257972A1 Plant proteins |
12/18/1997 | CA2257958A1 Identification and comparison of protein-protein interactions and inhibitors thereof |
12/18/1997 | CA2257916A1 Generating replicating molecules in vivo |
12/18/1997 | CA2257873A1 Use of substrate subtraction libraries to distinguish enzyme specificities |
12/18/1997 | CA2257871A1 Vectors and methods for tissue specific synthesis of protein in eggs of transgenic hens |
12/18/1997 | CA2257866A1 Rapid, accurate identification of dna sequence variants by electrospray mass spectrometry |
12/18/1997 | CA2257861A1 Hexameric fusion proteins and uses therefor |
12/18/1997 | CA2257829A1 Chitinase materials and methods |
12/18/1997 | CA2257828A1 Plant retinoblastoma-associated proteins |
12/18/1997 | CA2257373A1 Il-1/tnf-.alpha.-activated kinase (itak), and methods of making and using the same |
12/18/1997 | CA2257137A1 Synthetic hepatitis c genes |
12/18/1997 | CA2257111A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use |
12/18/1997 | CA2256710A1 Vaccine containing a peroxiredoxin and/or a .beta.-tubulin |
12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
12/18/1997 | CA2251575A1 Compounds that interfere with dna replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
12/18/1997 | CA2226945A1 Method for expressing foreign genes and vectors therefor |
12/18/1997 | CA2207852A1 Method for the purification of dna |
12/17/1997 | EP0812922A2 Polymorphisms in human mitochondrial nucleic acid |
12/17/1997 | EP0812921A2 Amplification and detection of chlamydia trachomatis nucleic acids |
12/17/1997 | EP0812918A2 Method of selection of allelic exchange mutants |
12/17/1997 | EP0812917A1 Cold-inducible promoter sequences |
12/17/1997 | EP0812916A2 Cathepsin k gene |
12/17/1997 | EP0812915A2 Polypeptide having beta-fructofuranosidase activity |
12/17/1997 | EP0812914A2 Prenyl diphosphate synthetase genes |
12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
12/17/1997 | EP0812912A1 RNA Catalyst for cleaving specific RNA sequences |
12/17/1997 | EP0812911A2 A method of forming a macromolecular microgene polymer |
12/17/1997 | EP0812910A1 Novel lipase gene and process for the production of lipase with the use of the same |
12/17/1997 | EP0812859A1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
12/17/1997 | EP0812621A1 Automated performance of the polymerase chain reaction |
12/17/1997 | EP0812594A1 Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds |
12/17/1997 | EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system |
12/17/1997 | EP0812361A1 A method for expressing modified recombinant proteins in a bacterial system |
12/17/1997 | EP0812360A1 Human geranylgeranyl pyrophosphate synthetase |
12/17/1997 | EP0812359A1 Group o hiv-1, fragments of such viruses, and uses thereof |
12/17/1997 | EP0812358A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
12/17/1997 | EP0812357A1 A method for making heteromultimeric polypeptides |
12/17/1997 | EP0812356A1 Prostate-specific membrane antigen and uses thereof |
12/17/1997 | EP0812355A2 Agent for treating tumours and other hyperplasia |
12/17/1997 | EP0812354A2 HUMAN RETINOID X RECEPTOR - GAMMA (hRXR-GAMMA) |
12/17/1997 | EP0812353A2 Prostaglandin receptor dp |
12/17/1997 | EP0812352A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
12/17/1997 | EP0812333A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
12/17/1997 | EP0812332A1 AN IMMUNOINTERACTIVE MOLECULE WHICH BINDS THE $i(TIE)2/TEK RECEPTOR EXTRACELLULAR DOMAIN |
12/17/1997 | EP0812331A1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
12/17/1997 | EP0812329A1 Human g-protein coupled receptor |
12/17/1997 | EP0812328A1 Insecticidal toxins from bracon hebetor |
12/17/1997 | EP0812209A1 Cochleate phospholipids in drug delivery |
12/17/1997 | EP0812207A1 Morphogen-induced dentine regeneration |
12/17/1997 | EP0812204A1 Codominance-mediated toxins |
12/17/1997 | EP0812203A1 Inhibitors of geranylgeranyl-protein transferase |
12/17/1997 | EP0812202A1 Galectin-8 and galectin-8-like proteins and dna molecules coding therefor |
12/17/1997 | EP0812129A1 Insecticidal peptides from spider venom |
12/17/1997 | EP0713494A4 Method of nucleic acid sequence selection |
12/17/1997 | EP0694079A4 Enzymatic ligation of 3'-amino-substituted olignucleotides |
12/17/1997 | EP0693132B1 Rapamycin assay |
12/17/1997 | EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
12/17/1997 | EP0557535B1 HUMAN MONOCLONAL ANTIBODY AGAINST GLYCOPROTEIN IIb/IIIa |
12/17/1997 | EP0494293B1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
12/17/1997 | EP0491739B1 Multi-functional enzymes including derivable 2',3'-didesoxyribofuranoside triphoshpates |
12/17/1997 | EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
12/17/1997 | EP0408675B1 Detection of human tumor progression and drug resistance |
12/17/1997 | CN1168176A A-protein as diagnostic of cancer |
12/17/1997 | CN1168156A Staphylokinase derivs. |
12/17/1997 | CN1168084A Stable compositions comprising transgenic plant material |
12/17/1997 | CN1167827A Negative related gene of large intestine cancer |
12/16/1997 | US5698766 A male transgenic mouse comprises a disrupted allel of th 5-ht2c serotonin receptor gene, and exhibits seizure and eating diorder |
12/16/1997 | US5698765 Mouse having a disrupted CD4 gene |
12/16/1997 | US5698764 Transgenic mice expressing HPV early region oncogene develop progressive epithelial neoplasia |